Related Experiment Video
Updated: Sep 8, 2025

Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface
Published on: October 20, 2023
α2,6-Sialylation is Upregulated in Severe COVID-19 Implicating the Complement Cascade
Rui Qin1, Emma Kurz2, Shuhui Chen3
1Department of Chemistry, University of Alberta, Edmonton, Alberta, Canada.
Insights
Severe COVID-19 involves hyper-inflammation. This study reveals increased alpha-2,6-sialylation and complement activation in severe cases, linking these processes to poor prognosis and fibrotic responses.
Area of Science:
- Biochemistry
- Immunology
- Pathology
Background:
- Understanding COVID-19 severity mechanisms is critical.
- Hyper-inflammation is a hallmark of severe COVID-19, but triggers remain unclear.
- The role of glycosylation in COVID-19 pathogenesis is unknown.
Approach:
- First high-throughput glycomic analysis of COVID-19 plasma and autopsy tissues.
- Investigated alpha-2,6-sialylation patterns in severe COVID-19.
- Examined the relationship between sialylation, complement activation, and disease markers.
Key Points:
- Alpha-2,6-sialylation is upregulated in plasma and lung tissue of severe COVID-19 patients.
- This glycan motif is enriched on complement cascade members.
- Increased sialylation correlates with complement deposition, IL-6, and fibrotic markers in lung tissue.
- The ST6GAL1 enzyme is upregulated in fatal COVID-19 cases.
Conclusions:
- Identified a novel link between sialylation and complement activation in severe COVID-19.
- Findings suggest sialylation plays a role in COVID-19-associated hyper-inflammation and pathology.
- This discovery may guide future therapeutic strategies for severe COVID-19.
Abstract:
Better understanding of the mechanisms of COVID-19 severity is desperately needed in current times. Although hyper-inflammation drives severe COVID-19, precise mechanisms triggering this cascade and what role glycosylation might play therein is unknown. Here we report the first high-throughput glycomic analysis of COVID-19 plasma samples and autopsy tissues. We find α2,6-sialylation is upregulated in plasma of patients with severe COVID-19 and in the lung. This glycan motif is enriched on members of the complement cascade, which show higher levels of sialylation in severe COVID-19. In the lung tissue, we observe increased complement deposition, associated with elevated α2,6-sialylation levels, corresponding to elevated markers of poor prognosis (IL-6) and fibrotic response. We also observe upregulation of the α2,6-sialylation enzyme ST6GAL1 in patients who succumbed to COVID-19. Our work identifies a heretofore undescribed relationship between sialylation and complement in severe COVID-19, potentially informing future therapeutic development.
More Related Videos
Related Concept Videos
Complement System
Proteoglycans
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Oligosaccharide Assembly
Multiple sugar molecules that may or may...

